Delivery Order SPE2DB22D1017-SPE2DB25FF9YV
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,907.97, is for the delivery of Valganciclovir 450 mg tablets. It is a firm fixed-price delivery order contract with a completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Valganciclovir 450 mg Tablets in 60-count packages. The $1,235.97 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valganciclovir 450 mg tablets, with a total ceiling value of $15,535.37 and a period of performance through March 12, 2025. The contract is not designated as a set-aside and was awarded under an existing Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a $127,208.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 60-count bottles of the generic drug valganciclovir 450 mg tablets. The order has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,158,577 units of Valganciclovir 450 mg tablets in 60-count packages, with a ceiling value of $3,526.68. It is a firm fixed-price delivery order contract with a performance period ending on May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,662.65 firm fixed-price contract is for the delivery of 60 tablets of the medication valganciclovir 450 mg. The contract has a performance period through January 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and there is no...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,605.14, is for the delivery of 60 count valganciclovir 450 mg tablets. It is a firm-fixed price delivery order with a completion date of December 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,530.43, is for the delivery of 60 tablets of valganciclovir 450 mg. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has a completion date of March 12, 2025 and was awarded on March 11, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,025.45 firm fixed-price delivery order is for the supply of 60 tablets of the medication Valganciclovir 450 mg. The contract has an ultimate completion date of March 21, 2025 and was awarded on March 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $5,291.30, is for the delivery of 4,566,065,391 units of valganciclovir 450 mg tablets over a two-year period ending in October 2024. The contract is structured as a fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded numerous...